Amiti Ventures focuses on deep-tech categories like quantum computing, server-class RISC-V compute, computational and synthetic biology, and physical AI, and it favors first-time technical founders who already know each other over adding a business cofounder, using Israel's tight-knit tech community to check how founders have actually worked together in the past. The fund also stands out for its team makeup—7 of 9 employees and two-thirds of leadership are women—for building diversity requirements directly into its term sheets, and for extending into computational biotech through AION Labs alongside companies like AstraZeneca, Merck, Pfizer, and Teva.